Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for advanced cancer: experimental drug IPN01195 enters human trials

NCT ID NCT06833008

Recruiting now Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests a new drug called IPN01195 in about 85 adults with advanced solid tumors that have spread and no longer respond to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants must have certain genetic changes in their tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMOR

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Léon Bérard - Lyon

    NOT_YET_RECRUITING

    Lyon, France

  • Hospital Universitario Quirónsalud Madrid

    RECRUITING

    Madrid, Spain

  • IGR-Villejuif

    RECRUITING

    Villejuif, France

  • Istituto Nazionale Tumori IRCCS - Fondazione Pascale

    RECRUITING

    Naples, Italy

  • Istituto Nazionale dei Tumori

    RECRUITING

    Milan, Italy

  • M.D. Anderson Center Madrid

    RECRUITING

    Madrid, Spain

  • Mary Crowley Cancer Research Centers - Medical City Hospital - Dallas

    RECRUITING

    Dallas, Texas, 75230, United States

  • Paris Saint-Louis

    RECRUITING

    Paris, France

  • START Mid-West

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • START Mountan Region

    RECRUITING

    West Valley City, Utah, 84119, United States

  • Sarah Cannon Research Institute (SCRI) - Nashville

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Val D'Hebron

    RECRUITING

    Barcelona, Spain

  • Virginia Cancer Specialist- Fairfax

    RECRUITING

    Fairfax, Virginia, 22031, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.